Phenominer

	Submit Data \| Help \| Video Tutorials \| News \| Publications \| Download \| REST API \| Citing RGD \| Contact
	Search RGD Grant Resources Citing RGD About Us Contact Us Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease Find Models new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive Pathways Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
	Advanced Search (OLGA)

Phenominer Database Results (9 results)

Colored By:

Table "column sort" updates the order of the bars in the chart.

Strain	Phenotype	Conditions	Study	Experiment Name	Sex	Age	# of Animals	Value	Units	SEM	SD	Method	Method Duration	Post Insult Time Value	Clinical Measurement Notes	Record ID	Study ID
MWF-Chr 6SHR/Rkb	negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value	control condition (for 0 hours)	Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.	vasoconstriction trait	male	84 days	10	8.1	null	0.1	0.32	wire myography	0.0	0	logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677)	109386	3141
MWF/FubRkb	negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value	vehicle control condition (for 28 days)	Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.	vasoconstriction trait	male	114 days	10	6.9	null	0.1	0.32	wire myography	0.0	0		109445	3140
MWF/FubRkb	negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value	finerenone (for 28 days)	Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.	vasoconstriction trait	male	114 days	10	6.7	null	0.1	0.32	wire myography	0.0	0		109446	3140
Crl:WI	negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value	vehicle control condition (for 28 days)	Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.	vasoconstriction trait	male	114 days	10	6.7	null	0.1	0.32	wire myography	0.0	0		109443	3140
MWF-Chr 8SHR/Rkb	negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value	control condition (for 0 hours)	Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.	vasoconstriction trait	male	84 days	10	7.7	null	0.1	0.32	wire myography	0.0	0	logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677)	109385	3141
SHR/FubRkb	negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value	control condition (for 0 hours)	Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.	vasoconstriction trait	male	84 days	10	7.6	null	0.2	0.63	wire myography	0.0	0	logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677)	109383	3141
MWF/FubRkb	negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value	control condition (for 0 hours)	Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.	vasoconstriction trait	male	84 days	10	8.3	null	0.2	0.63	wire myography	0.0	0	logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677)	109384	3141
Crl:WI	negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value	finerenone (for 28 days)	Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275.	vasoconstriction trait	male	114 days	10	6.9	null	0.1	0.32	wire myography	0.0	0		109444	3140
WKY/NCrl	negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value	control condition (for 0 hours)	Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384.	vasoconstriction trait	male	84 days	10	7.8	null	0.2	0.63	wire myography	0.0	0	logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677)	109382	3141

Contact Us | About Us | Jobs at RGD

© Bioinformatics Program, HMGC at the Medical College of Wisconsin

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.
NHLBI Logo